|
|
|
Volumn 11, Issue 3, 2008, Pages 198-203
|
|
Hepatocellular carcinoma (HCC): Current and evolving therapies
|
|
Author keywords
Chemoembolization; Hepatocellular carcinoma (HCC); Kinase inhibitors; Percutaneous ablation; Sorafenib
|
|
Indexed keywords
6 HYDROXYMETHYLACYLFULVENE;
ALPHA FETOPROTEIN;
ALPHA INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
CISPLATIN;
CPG OLIGODEOXYNUCLEOTIDE;
CYTARABINE;
DOXORUBICIN;
ERLOTINIB;
FENRETINIDE;
FLOXURIDINE;
FLUOROURACIL;
G 207;
GEMCITABINE;
IMATINIB;
INTERFERON;
INTERLEUKIN 2;
IROFULVEN;
OCTREOTIDE;
OXALIPLATIN;
PLACEBO;
POLYPRENOIC ACID;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
RETINOID;
SORAFENIB;
TUMOR VACCINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VATALANIB;
ADVANCED CANCER;
ARTIFICIAL EMBOLISM;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER THERAPY;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COOLING;
DIARRHEA;
DRUG DELIVERY SYSTEM;
HAND FOOT SYNDROME;
HEATING;
HUMAN;
IMMUNOTHERAPY;
INJECTION;
INTERVENTION STUDY;
LIVER;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
REVIEW;
SURVIVAL RATE;
TUMOR CELL;
UNITED STATES;
CARCINOMA, HEPATOCELLULAR;
COMBINED MODALITY THERAPY;
HUMANS;
LIVER NEOPLASMS;
|
|
EID: 40049097814
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (27)
|
|
References (0)
|
